RESUMEN
In recent years, accumulating evidence has indicated that platelets continuously repair vascular damage at sites of inflammation and/or infection. Studies in mouse models of inflammation have highlighted the fact that the mechanisms underlying bleeding prevention by platelets in inflamed organs can substantially differ from those supporting primary hemostasis following tail tip transection or thrombus formation in models of thrombosis. As a consequence, exploration of the hemostatic function of platelets in inflammation, as well as assessment of the risk of inflammation-induced bleeding associated with a platelet deficit and/or the use of anti-thrombotic drugs, require the use of dedicated experimental models. In the present review, we present the pros and cons of the cutaneous reversed passive Arthus reaction, a model of inflammation which has been instrumental in studying how inflammation causes vascular injury and how platelets continuously intervene to repair it. The limitations and common issues encountered when working with mouse models of inflammation for investigating platelet functions in inflammation are also discussed.
Asunto(s)
Reacción de Arthus/inmunología , Plaquetas/metabolismo , Hemostasis/inmunología , Inflamación/inmunología , Animales , Reacción de Arthus/tratamiento farmacológico , Reacción de Arthus/genética , Reacción de Arthus/fisiopatología , Plaquetas/enzimología , Plaquetas/inmunología , Plaquetas/patología , Modelos Animales de Enfermedad , Hemorragia/inmunología , Hemorragia/patología , Hemostasis/efectos de los fármacos , Hemostasis/genética , Inflamación/tratamiento farmacológico , Inflamación/genética , Ratones , Trombosis/tratamiento farmacológico , Trombosis/genética , Trombosis/fisiopatologíaRESUMEN
Recent compelling evidence has lead to renewed interest in the role of antibodies and immune complexes in the pathogenesis of several autoimmune disorders, such as rheumatoid arthritis. These immune complexes, consisting of autoantibodies to self-antigens, can mediate inflammatory responses largely through binding and activating the immunoglobulin Fc receptors (FcRs). Using cell-based structure activity relationships with cultured human mast cells, we have identified the small molecule R406 [N4-(2,2-dimethyl-3-oxo-4H-pyrid[1,4]oxazin-6-yl)-5-fluoro-N2-(3,4,5-trimethoxyphenyl)-2,4-pyrimidinediamine] as a potent inhibitor of immunoglobulin E (IgE)- and IgG-mediated activation of Fc receptor signaling (EC(50) for degranulation = 56-64 nM). Here we show that the primary target for R406 is the spleen tyrosine kinase (Syk), which plays a key role in the signaling of activating Fc receptors and the B-cell receptor (BCR). R406 inhibited phosphorylation of Syk substrate linker for activation of T cells in mast cells and B-cell linker protein/SLP65 in B cells. R406 bound to the ATP binding pocket of Syk and inhibited its kinase activity as an ATP-competitive inhibitor (K(i) = 30 nM). Furthermore, R406 blocked Syk-dependent FcR-mediated activation of monocytes/macrophages and neutrophils and BCR-mediated activation of B lymphocytes. R406 was selective as assessed using a large panel of Syk-independent cell-based assays representing both specific and general signaling pathways. Consistent with Syk inhibition, oral administration of R406 to mice reduced immune complex-mediated inflammation in a reverse-passive Arthus reaction and two antibody-induced arthritis models. Finally, we report a first-inhuman study showing that R406 is orally bioavailable, achieving exposures capable of inhibiting Syk-dependent IgE-mediated basophil activation. Collectively, the results show R406 potential for modulating Syk activity in human disease.
Asunto(s)
Complejo Antígeno-Anticuerpo/fisiología , Inhibidores Enzimáticos/farmacología , Inflamación/tratamiento farmacológico , Oxazinas/farmacología , Proteínas Tirosina Quinasas/antagonistas & inhibidores , Piridinas/farmacología , Receptores Fc/antagonistas & inhibidores , Transducción de Señal/efectos de los fármacos , Bazo/enzimología , Animales , Artritis Experimental/patología , Reacción de Arthus/fisiopatología , Linfocitos B/efectos de los fármacos , Linfocitos B/fisiología , Basófilos/efectos de los fármacos , Western Blotting , Células Cultivadas , Cristalografía , Método Doble Ciego , Inhibidores Enzimáticos/farmacocinética , Inmunoensayo de Polarización Fluorescente , Humanos , Inmunoglobulina G/biosíntesis , Inmunoglobulina G/inmunología , Inflamación/patología , Lipopolisacáridos/farmacología , Macrófagos/efectos de los fármacos , Mastocitos/efectos de los fármacos , Ratones , Ratones Endogámicos BALB C , Oxazinas/farmacocinética , Agregación Plaquetaria/efectos de los fármacos , Piridinas/farmacocinética , Estimulación Química , Acetato de Tetradecanoilforbol/farmacologíaRESUMEN
Staphylococcal protein A (SpA) is representative of a new class of antigens, the B-cell superantigens (SAgs). These antigens bind to the Fab regions of immunoglobulin molecules outside their complementarity-determining regions. SpA, the best-studied B-cell SAg, reacts with the Fabs of most VH3+ immunoglobulins, which are expressed on 30 to 60% of human peripheral B cells. Therefore, B-cell SAgs like SpA have great potential to elicit inflammatory responses in vivo. We previously reported that the interaction of SpA with VH3+ immunoglobulin molecules leads to activation of the complement cascade and produces a histologic pattern of inflammation in the skin of a rabbit indicative of immune complex injury. To elucidate the cellular and molecular events contributing to this type of unconventional immune complex-mediated inflammation, we established a mouse peritoneal Arthus reaction model. Mice treated intravenously with human polyclonal immunoglobulin G (IgG), followed by intraperitoneal injection of SpA, showed neutrophil influx into the peritoneal cavity with peak numbers appearing at 8 h. This inflammatory reaction was dependent on the interaction of SpA with VH3+ IgG. Mast cells, FcgammaRIII, complement components, and tumor necrosis factor alpha play obligatory roles, and the reaction is associated with the local release of the CXC chemokines macrophage inflammatory protein 2 and KC. The data provide further compelling evidence for the induction of immune complex-mediated injury by a B-cell SAg and highlight important factors contributing to the pathogenesis of this novel type of inflammatory reaction.
Asunto(s)
Reacción de Arthus/inmunología , Reacción de Arthus/fisiopatología , Linfocitos B/inmunología , Inmunoglobulina G/administración & dosificación , Proteína Estafilocócica A/administración & dosificación , Superantígenos/administración & dosificación , Animales , Reacción de Arthus/etiología , Linfocitos B/metabolismo , Femenino , Humanos , Inmunoglobulina G/inmunología , Inmunoglobulina G/metabolismo , Cadenas Pesadas de Inmunoglobulina/administración & dosificación , Cadenas Pesadas de Inmunoglobulina/inmunología , Región Variable de Inmunoglobulina/administración & dosificación , Región Variable de Inmunoglobulina/inmunología , Ratones , Ratones Endogámicos BALB C , Infiltración Neutrófila , Neutrófilos/inmunología , Cavidad Peritoneal/fisiopatología , Proteína Estafilocócica A/inmunología , Proteína Estafilocócica A/metabolismo , Superantígenos/inmunología , Superantígenos/metabolismoRESUMEN
Supramolecular micellar structures have been proposed as carriers in aim-oriented drug transportation to a target marked by specific immune complexes. In this study, the self-assembling dye Congo red was used as a model supramolecular carrier and its accumulation in the target was studied in vivo. The target was created in vivo as the local specific inflammation provoked by subcutaneous injection of antigen to the ear of a previously immunized rabbit. The color caused by accumulation of Congo red after its intravenous injection was registered by pictures of the ear with suitably filtered visible light shining through it to distinguish Congo red against the background color of hemoglobin. The results confirmed the expected accumulation and retention of Congo red in the inflammation area marked by deposits of specific immune complexes. The role of albumin and its possible interference with transportation of drugs through the blood by supramolecular carriers was also subjected to preliminary examination. The results revealed that albumin collaborates rather than interferes with drug transportation; this is another factor making the use of supramolecular carriers for aim-oriented chemotherapy highly promising.
Asunto(s)
Complejo Antígeno-Anticuerpo/metabolismo , Rojo Congo/metabolismo , Rojo Congo/farmacocinética , Oído/fisiopatología , Albúminas/química , Albúminas/metabolismo , Animales , Reacción de Arthus/metabolismo , Reacción de Arthus/patología , Reacción de Arthus/fisiopatología , Colorantes/química , Colorantes/metabolismo , Colorantes/farmacocinética , Rojo Congo/química , Quimioterapia/métodos , Inmunohistoquímica , Cinética , Modelos Moleculares , Estructura Molecular , Conejos , Rodaminas/química , Rodaminas/metabolismoRESUMEN
Many adhesion molecule pathways have been invoked as mediating leukocyte recruitment during immune complex-induced inflammation. However the individual roles of these molecules have not been identified via direct visualization of an affected microvasculature. Therefore, to identify the specific adhesion molecules responsible for leukocyte rolling and adhesion in immune complex-dependent inflammation we used intravital microscopy to examine postcapillary venules in the mouse cremaster muscle. Wild-type mice underwent an intrascrotal reverse-passive Arthus model of immune complex-dependent inflammation and subsequently, leukocyte-endothelial cell interactions and P- and E-selectin expression were assessed in cremasteric postcapillary venules. At 4 hours, the reverse-passive Arthus response induced a significant reduction in leukocyte rolling velocity and significant increases in adhesion and emigration. P-selectin expression was increased above constitutive levels whereas E-selectin showed a transient induction of expression peaking between 2.5 to 4 hours and declining thereafter. While E-selectin was expressed, rolling could only be eliminated by combined blockade of P- and E-selectin. However, by 8 hours, all rolling was P-selectin-dependent. In contrast, inhibition of vascular cell adhesion molecule-1 had a minimal effect on leukocyte rolling, but significantly reduced both adhesion and emigration. These observations demonstrate that immune complex-mediated leukocyte recruitment in the cremaster muscle involves overlapping roles for the endothelial selectins and vascular cell adhesion molecule-1.
Asunto(s)
Músculos Abdominales/irrigación sanguínea , Complejo Antígeno-Anticuerpo/inmunología , Reacción de Arthus/fisiopatología , Endotelio Vascular/metabolismo , Leucocitos , Selectinas/metabolismo , Molécula 1 de Adhesión Celular Vascular/metabolismo , Animales , Complejo Antígeno-Anticuerpo/metabolismo , Reacción de Arthus/inmunología , Reacción de Arthus/metabolismo , Adhesión Celular , Selectina E/metabolismo , Ratones , Ratones Endogámicos C57BL , Microcirculación , Selectina-P/metabolismo , Regulación hacia ArribaRESUMEN
Immune complex-induced tissue injury is mediated by inflammatory cell infiltration that is highly regulated by multiple adhesion molecules. To assess the relative contribution of adhesion molecules, including selectins and ICAM-1, in this pathogenetic process, the cutaneous passive Arthus reaction was examined in mice lacking E-selectin, P-selectin, or both L-selectin and ICAM-1 with anti-P- or E-selectin mAbs. Edema and hemorrhage were significantly reduced in P-selectin(-/-) mice compared with wild-type mice while they were not inhibited in E-selectin(-/-) mice. Combined E- and P-selectin blockade resulted in more significant reduction relative to L-selectin/ICAM-1(-/-) as well as P-selectin(-/-) mice. Remarkably, both E- and P-selectin blockade in L-selectin/ICAM-1(-/-) mice completely abrogated edema and hemorrhage. The inhibited edema and hemorrhage paralleled reduced infiltration of neutrophils and mast cells that expressed significant levels of P-selectin glycoprotein ligand-1. Similarly reduced infiltration of neutrophils and mast cells was observed in the peritoneal Arthus reaction and was associated partly with the decreased production of tumor necrosis factor-alpha and interleukin-6. The results of this study indicate that both endothelial selectins contribute predominantly to the Arthus reaction by regulating mast cell and neutrophil infiltration and that the full development of the Arthus reaction is mediated cooperatively by all selectins and ICAM-1.
Asunto(s)
Selectina E/fisiología , Enfermedades del Complejo Inmune/patología , Molécula 1 de Adhesión Intercelular/fisiología , Selectina-P/fisiología , Selectinas/fisiología , Animales , Reacción de Arthus/genética , Reacción de Arthus/patología , Reacción de Arthus/fisiopatología , Moléculas de Adhesión Celular/fisiología , Selectina E/genética , Edema/genética , Edema/patología , Edema/fisiopatología , Hemorragia/genética , Hemorragia/patología , Hemorragia/fisiopatología , Inflamación/patología , Inflamación/fisiopatología , Molécula 1 de Adhesión Intercelular/genética , Ratones , Ratones Noqueados , Selectina-P/genéticaRESUMEN
BACKGROUND/AIMS: The Arthus type allergic reaction is characterised by inflammatory cell infiltration and marked neovascularisation in the cornea. During the healing stages, inflammatory cells and newly formed microvessels gradually disappear. The aim was to establish whether apoptosis affected the regression of inflammatory cells and newly formed microvessels, in order to define more clearly the cellular mechanisms involved in the pathobiology of corneal diseases. METHODS: Albino male rabbits were injected subcutaneously with 5 mg/ml bovine serum albumin (BSA) incorporated in Freund's complete adjuvant twice weekly. Under the anaesthesia, 30 microl of a 0.5 mg/ml BSA solution was injected into the central corneal stroma to induce an Arthus type allergic reaction. The injured corneas were collected at various time points ranging from 3 to 20 days. Apoptotic cells were identified by both light microscopy using in situ TdT-dUTP nick end labelling (TUNEL) method and electron microscopy. RESULTS: With increasing time after induction of the Arthus reaction, marked neovascularisation and infiltrated inflammatory cells such as polymorphonuclear cells (PMNs) and plasma cells were observed in the cornea. Thereafter, the inflammatory cells and newly formed microvessels gradually disappeared. Coincidently, the numbers of microvessel endothelial cells and infiltrated inflammatory cells undergoing apoptosis were increased. Apoptotic bodies were taken up by macrophages, PMNs, as well as myofibroblasts derived presumably from transformation of migrated keratocytes. CONCLUSIONS: These data demonstrate that regression of the cellular infiltrates and microvessel endothelial cells associated with the Arthus reaction in the cornea occurs via apoptosis. This finding adds insights into the cellular mechanisms regulating the pathobiology of corneal diseases.
Asunto(s)
Apoptosis/fisiología , Reacción de Arthus/patología , Córnea/patología , Animales , Reacción de Arthus/fisiopatología , Neovascularización de la Córnea/fisiopatología , Etiquetado Corte-Fin in Situ , Macrófagos/fisiología , Masculino , Microscopía Electrónica , Microscopía Fluorescente , Infiltración Neutrófila , Fagocitosis/fisiología , Conejos , Remisión EspontáneaRESUMEN
The present study was designed to establish the influence of chronic social isolation stress on humoral and cellular immunity in nucleus basalis magnocellularis (NBM)-lesioned rats. Therefore, ten days after bilateral electrolytic lesions of NBM, adult male Wistar rats were immunized with bovine serum albumin in complete Freund's adjuvant (BSA-CFA) and placed individually or in groups of five rats during 21 days. On days 10 and 21 after immunization, the Arthus and delayed hypersensitivity skin reactions to BSA as well as anti-BSA antibody production were determined. On day 10, the diameter and intensity of delayed hypersensitivity skin reaction to BSA were significantly higher in social-isolated rats in comparison with the group-reared ones. On day 21, the diameter and intensity of the Arthus skin reaction were significantly higher in social-isolated rats compared to group-reared rats. Between days 10 and 21, the diameter and intensity of the Arthus skin reaction significantly increased in social-isolated rats, while the diameter of delayed hypersensitivity skin reaction significantly decreased. In contrast to social-isolated rats, there were no significant differences in Arthus and delayed hypersensitivity skin reactions in group-reared rats, between days 10 and 21. Also there were no significant differences in the production of anti-BSA antibody between social-isolated and group-reared rats. The relative spleen weight was significantly lower in social-isolated rats. These data suggest that chronic isolation stress modify humoral and cellular immunity in NBM-lesioned rats.
Asunto(s)
Reacción de Arthus/inmunología , Tolerancia Inmunológica/inmunología , Aislamiento Social , Bazo/patología , Estrés Psicológico/inmunología , Animales , Formación de Anticuerpos/inmunología , Reacción de Arthus/inducido químicamente , Reacción de Arthus/fisiopatología , Núcleo Basal de Meynert/lesiones , Bovinos , Adyuvante de Freund , Masculino , Tamaño de los Órganos , Ratas , Ratas Wistar , Albúmina Sérica Bovina , Estrés Psicológico/fisiopatologíaRESUMEN
A passive Arthus reaction (AR) induced in the peritoneal cavity of mice was followed by increased local vascular permeability and haemoconcentration. The intensity of the increased vasopermeability was higher in BALB/c compared with C3H/HePas mice despite the latter being 10 times more sensitive to platelet-activating factor (PAF). C3H/HePas mice however, exhibited higher levels of haemoconcentration and shock-like symptoms. Both events were inhibited by the PAF antagonist, WEB 2170. Indomethacin reduced both pathological events whereas L663,536, that inhibits leukotrienes synthesis reduced haemoconcentration but only in BALB/c mice. PAF was released into the peritoneal cavity, peak release being at 10 min after induction of AR. Prostaglandin E2 (PGE2), thromboxane B2 (TXB2), leukotriene B4 (LTB4), and leukotriene C4/D4 (LTC4/D4) were also released at this time. Similar levels of PAF and eicosanoids were found in BALB/c and C3H/HePas mice except for LTB4, which was higher in C3H/HePas. It is concluded that PAF and eicosanoids are mediators of local and systemic changes induced by immune complexes in the peritoneal cavity of mice.
Asunto(s)
Complejo Antígeno-Anticuerpo/fisiología , Reacción de Arthus/fisiopatología , Eicosanoides/fisiología , Factor de Activación Plaquetaria/fisiología , Animales , Permeabilidad Capilar , Eicosanoides/metabolismo , Ratones , Ratones Endogámicos BALB C , Ratones Endogámicos C3H , Cavidad Peritoneal , Factor de Activación Plaquetaria/metabolismo , Especificidad de la EspecieRESUMEN
A number of pro-inflammatory mediators (leukotrienes, platelet activating factor, cytokines) participate in the process of neutrophil-dependent lung injury induced by immune complexes. Here, we studied the role of endothelins (ET) in the reversed passive Arthus reaction (AR) as a model of pneumonitis in CD-1 mice. We examined the broncholaveolar lavage fluid (BALF) for signs of inflammation such as the accumulation of cells, myeloperoxidase (MPO) activity and hemoglobin (Hb) levels, as a measure of hemorrhagic lesions, 24 h after injection. We used a selective ETA (BQ-123) or a non-selective ETA/ETB-R (SB 209670) receptor antagonist at various concentrations (2.5, 5 or 10 mg/kg ip at -8, 0, 8 and 16 h) to assess the involvement of ET. Challenged mice revealed signs of acute inflammation and hemorrhagic lesions. Levels of Hb and MPO, total and neutrophil cell counts increased by 9-, 9-, 3.2- and 63-fold, respectively. The lower dose of SB 209670 reduced Hb levels by 21% (P<0.05), without affecting cell accumulation or MPO. The mid-dose had no effect; the highest dose caused 60, 57 and 70% increases in Hb levels, total cell and neutrophil counts, respectively. Conversely, the highest dose of BQ-123 decreased Hb, total cell and neutrophil counts and MPO levels by 36, 35, 42 and 70%, respectively. These results support a role for ET in AR lung injuries. They also suggests that blocking ETA-R may be beneficial, while blockade of ETB-R (using a high dose of SB 209670) may be detrimental. A beneficial ETB-mediated response may exist that naturally interferes with events triggered by the formation of immune complexes such as cell accumulation and their subsequent activation leading to acute lung injury.
Asunto(s)
Complejo Antígeno-Anticuerpo/inmunología , Reacción de Arthus/inmunología , Endotelinas/fisiología , Neumonía/inmunología , Receptores de Endotelina/fisiología , Animales , Reacción de Arthus/fisiopatología , Líquido del Lavado Bronquioalveolar/inmunología , Hemoglobinas/análisis , Hemorragia/inmunología , Hemorragia/fisiopatología , Indanos/administración & dosificación , Indanos/farmacología , Pulmón/inmunología , Pulmón/patología , Ratones , Neutrófilos/fisiología , Peroxidasa/análisis , Neumonía/fisiopatologíaRESUMEN
Knockout mice lacking either the antibody constant region (Fc) receptor or the substance P receptor fail to produce a model inflammatory response, implicating these two receptors in early events of inflammation.
Asunto(s)
Inflamación/fisiopatología , Animales , Reacción de Arthus/fisiopatología , Humanos , Ratones , Ratones Noqueados , Receptores Fc/genética , Receptores Fc/fisiología , Receptores de Neuroquinina-1/genética , Receptores de Neuroquinina-1/fisiologíaRESUMEN
The CD11/CD18 leukocyte integrins are necessary for tissue localization of neutrophils, an early requisite event in inflammation. We have analyzed the contribution of CD11a/CD18 and CD11b/CD18 to local neutrophil accumulation and tissue injury in the reverse passive Arthus reaction in the rat dermis. Experimental groups comprised animals that received an intravenous infusion of (1) recombinant neutrophil inhibitory factor (NIF), a hookworm-derived antagonist of CD11b/CD18; (2) monoclonal antibody to CD11a/CD18 (TA-3); (3) a combination of these agents; (4) a monoclonal antibody to CD18 (WT.3); or (5) saline. Administration of recombinant NIF or anti-CD11a/CD18 monoclonal antibody alone produced a slight reduction in neutrophil accumulation but did not affect edema formation. In contrast, a combination of these antagonists yielded a significant reduction in neutrophil accumulation and a modest reduction in edema, equivalent to levels observed with either anti-CD18 antibodies or animals that were rendered neutropenic. These results indicate that neutrophil infiltration in rat dermal tissue in the reverse passive Arthus reaction is dependent predominantly on the leukocyte integrins CD11a/CD18 and CD11b/CD18 and that either of these integrins is sufficient for neutrophil trafficking in this inflammatory setting.
Asunto(s)
Reacción de Arthus/fisiopatología , Antígenos CD11/fisiología , Antígenos CD18/fisiología , Dermatitis/fisiopatología , Proteínas de la Membrana , Animales , Anticuerpos Monoclonales/farmacología , Reacción de Arthus/tratamiento farmacológico , Reacción de Arthus/patología , Antígenos CD11/efectos de los fármacos , Antígenos CD11/inmunología , Antígenos CD18/efectos de los fármacos , Antígenos CD18/inmunología , Células CHO , Cricetinae , Dermatitis/tratamiento farmacológico , Dermatitis/patología , Edema/tratamiento farmacológico , Edema/inmunología , Edema/patología , Glicoproteínas/farmacología , Proteínas del Helminto/farmacología , Masculino , Neutrófilos/efectos de los fármacos , Neutrófilos/inmunología , Neutrófilos/patología , Conejos , Ratas , Proteínas Recombinantes/farmacologíaAsunto(s)
Reacción de Arthus/fisiopatología , Molécula 1 de Adhesión Intercelular/fisiología , Pleuresia/fisiopatología , Animales , Anticuerpos Monoclonales/inmunología , Reacción de Arthus/inmunología , Electroforesis en Gel de Poliacrilamida , Endotelio Vascular/citología , Endotelio Vascular/efectos de los fármacos , Endotelio Vascular/metabolismo , Fragmentos Fab de Inmunoglobulinas/inmunología , Neutrófilos/efectos de los fármacos , Neutrófilos/metabolismo , Pleuresia/inmunología , RatasRESUMEN
1. The involvement of platelet-activating factor (PAF) in immune complex-induced/polymorphonuclear-mediated tissue injury was studied by use of a reverse passive Arthus (RPA) model in the peritoneal cavity of rats. 2. Extravasation of protein-rich plasma, accumulation of polymorphonuclear leukocytes (PMN), and the production of nitric oxide (NO) by resident peritoneal mononuclear phagocytes were assayed. 3. Treatment of rats with either UR-12460 or BB-823, two compounds which possess different chemical structures, but elicit the same antagonistic effect on the PAF receptor, abrogated protein-rich plasma extravasation. In contrast, they did not show any effect on the accumulation of PMN. 4. Inhibition of NO production with both NG-mono methyl-L-arginine and NG-nitro-L-arginine failed to prevent protein-rich plasma extravasation. 5. The production of NO by peritoneal adherent cells following RPA was measured in cells maintained for 2 to 28 h in culture, and it was significantly increased in cells removed as early as 15 min after RPA induction, as compared to controls. 6. Addition of 10 nM PAF to the culture medium reduced the generation of NO by peritoneal cells from RPA rats, whereas this mediator enhanced NO production in cells from naive control animals. 7. Treatment with either UR-12460 or BB-823 prior to the induction of RPA produced an almost complete inhibition of NO production. 8. Assay of nitric oxide synthase activity in cell homogenates from peritoneal cells showed that the activity was due to the inducible form of the enzyme. 9. Study by Northen blotting of mRNA coding for the inducible NO synthase (iNOS) showed transcription at 6 and 18 h after the induction of RPA, which was inhibited in UR-12460-treated rats.10. These data indicate that PAF is the main mediator of the early plasma leakage observed in RPA,and also that PAF is implicated in the triggering of long-term changes via induction of specific genes, as judged from its ability to promote the expression of iNOS.
Asunto(s)
Aminoácido Oxidorreductasas/biosíntesis , Neutrófilos/metabolismo , Óxido Nítrico/antagonistas & inhibidores , Peritonitis/inmunología , Factor de Activación Plaquetaria/inmunología , Receptores de Superficie Celular , Receptores Acoplados a Proteínas G , Análisis de Varianza , Animales , Formación de Anticuerpos/efectos de los fármacos , Arginina/análogos & derivados , Arginina/farmacología , Reacción de Arthus/fisiopatología , Northern Blotting , Células Cultivadas , Inducción Enzimática/efectos de los fármacos , Extravasación de Materiales Terapéuticos y Diagnósticos , Leucina/análogos & derivados , Leucina/farmacología , Masculino , NG-Nitroarginina Metil Éster , Neutrófilos/efectos de los fármacos , Óxido Nítrico Sintasa , Cavidad Peritoneal/fisiopatología , Fagocitos/efectos de los fármacos , Fagocitos/metabolismo , Piperazinas/farmacología , Factor de Activación Plaquetaria/metabolismo , Glicoproteínas de Membrana Plaquetaria/antagonistas & inhibidores , Ratas , Ratas Wistar , Organismos Libres de Patógenos Específicos , omega-N-MetilargininaRESUMEN
1. The role of arachidonic acid metabolites and oxygen radicals in carrageenin-induced rat paw oedema and dermal reverse passive Arthus reaction (RPA) have been investigated. 2. Indomethacin (10 mg kg-1, p.o.) inhibited carrageenin paw oedema when administered 30 min before, but not 2 h after carrageenin. BWB70C (10 mg kg-1, p.o.), a selective inhibitor of 5-lipoxygenase, had no effect whether administered before or after carrageenin. Administration of both indomethacin and BWB70C had no greater anti-inflammatory effect than indomethacin alone. 3. BW755C (20 mg kg-1, p.o.), which inhibits the cyclo-oxygenase and lipoxygenase pathways of arachidonic acid metabolism, or superoxide dismutase-polyethylene glycol conjugate (SOD-PEG, 3000 u, i.v.) inhibited carrageenin paw oedema whether administered either 30 min before, or 2 h after carrageenin. 4. Pretreatment with dexamethasone (0.1 mg kg-1) or colchicine (2 mg kg-1), likewise suppressed carrageenin paw oedema. 5. BW755C (25-100 mg kg-1, p.o.) dose-dependently reduced plasma leakage in the RPA, whereas indomethacin (5 mg kg-1, p.o.) or BWB70C either alone or in combination, did not. 6. SOD-PEG (300-3000 u, i.v.) dose-dependently inhibited plasma leakage in the RPA. In addition, the iron chelator and peroxyl radical scavenger, desferrioxamine (200 mg kg-1, s.c.) also inhibited plasma leakage. 7. Pretreatment with dexamethasone (0.1 mg kg-1) or colchicine (1 mg kg-1) reduced the plasma leakage in RPA, whereas MK-886 (10 mg kg-1) had no effect. 8. These results indicate an important role for oxygen radicals but not arachidonic acid metabolites in the maintenance of carrageenin paw oedema and the plasma leakage in RPA. Furthermore, the results suggest that the anti-inflammatory actions of BW755C can be dissociated from its effects on arachidonic acid metabolism and are attributed to its anti-oxidant activity.
Asunto(s)
Antioxidantes/farmacología , Ácido Araquidónico/fisiología , Reacción de Arthus/fisiopatología , Edema/fisiopatología , Especies Reactivas de Oxígeno/metabolismo , 4,5-dihidro-1-(3-(trifluorometil)fenil)-1H-pirazol-3-amina/farmacología , Animales , Carragenina , Colchicina/farmacología , Inhibidores de la Ciclooxigenasa/farmacología , Deferoxamina/farmacología , Dexametasona/farmacología , Edema/inducido químicamente , Inhibidores de la Lipooxigenasa/farmacología , Masculino , Peroxidasa/metabolismo , Ratas , Ratas Wistar , Superóxido Dismutasa/metabolismoRESUMEN
1. The contribution of platelet-activating factor (PAF) to platelet deposition and oedema formation induced by exogenous soluble mediators, zymosan particles and associated with a reversed passive Arthus (RPA) reaction in rabbit skin was investigated by use of a novel long-acting PAF receptor antagonist, UK-74,505. 2. Oedema formation and platelet accumulation were simultaneously measured by i.v. injection of [125I]-albumin and 111In-labelled rabbit platelets. UK-74,505 was either administered i.v. or used to pretreat radiolabelled platelets in vitro before their injection into recipient animals. Platelets pretreated with UK-74,505 were also labelled with the fluorescent calcium indicator, Fura-2, to assess their ex vivo reactivity to PAF at the end of the in vivo experiment. 3. UK-74,505 (0.5 mg kg-1), administered i.v., inhibited PAF-induced oedema formation, but did not affect oedema induced by zymosan particles, bradykinin (BK), histamine, formyl-methionyl-leucylphenylalanine (FMLP), zymosan-activated plasma (ZAP, as a source of C5a des Arg), leukotriene B4 (LTB4) or interleukin-8 (IL-8). 4. UK-74,505, administered i.v. also suppressed the small platelet accumulation induced by exogenous PAF, but had no effect on accumulation induced by IL-8 or ZAP. Although oedema induced by zymosan was not affected by i.v. UK-74,505, zymosan-induced platelet accumulation was significantly attenuated by the antagonist. 5. The RPA reaction in rabbit skin was associated with marked oedema formation and platelet accumulation which were both inhibited by i.v. UK-74,505. 6. In vitro, UK-74,505 inhibited aggregation and the increase in intracellular calcium concentration induced by PAF in rabbit washed platelets in a concentration-dependent manner (IC50 = 1.6 x 10-8 M and 1.1 x 10-8 M, respectively). Platelets pretreated with 10-6 M UK-74,505, and maintained at 37 degrees C,were unresponsive to PAF, whilst responding normally to thrombin, for up to 4 h.7. In a second series of in vivo experiments, platelets were labelled with 111In and loaded with Fura-2.The platelets were then pretreated with 10-6 M UK-74,505, washed, and injected into recipient rabbits.These platelets, prepared from blood samples taken at the end of the in vivo experiments, exhibited an 80% reduction in their response to PAF as measured ex vivo with Fura-2. However, in contrast to the effects of i.v. UK-74,505, platelets pretreated with the antagonist did accumulate effectively in the RPA reaction, a significant reduction only being observed in responses at the lowest antibody dose. In addition, pretreatment of platelets had no effect on the small platelet accumulation induced by PAF.8. These results suggest that PAF is an important mediator of oedema formation and platelet accumulation in the RPA reaction in rabbit skin. However, they question the role of PAF receptors on platelets in this model. The results also indicate that PAF may be involved in platelet accumulation induced by zymosan in rabbit skin.
Asunto(s)
Plaquetas/fisiología , Dihidropiridinas/farmacología , Imidazoles/farmacología , Factor de Activación Plaquetaria/fisiología , Piel/citología , Animales , Reacción de Arthus/fisiopatología , Plaquetas/efectos de los fármacos , Calcio/sangre , Edema/inducido químicamente , Edema/patología , Fura-2/farmacología , Técnicas In Vitro , Radioisótopos de Indio , Factor de Activación Plaquetaria/antagonistas & inhibidores , Agregación Plaquetaria/efectos de los fármacos , Conejos , Albúmina Sérica/metabolismo , Piel/efectos de los fármacos , Zimosan/farmacologíaRESUMEN
Plasma exudation characterizes the early phase of acute inflammation. The possible role of mast cells and their mediators in this event in immune complex-induced injury was studied. Dye exudation was assessed from 5 min to 2 hr after initiating reverse passive Arthus reaction in mast cell-deficient mice, WBB6F1-W/Wv (W/Wv), and their normal congenic controls, WBB6F1-+/+ (+/+). The response to antibody (10, 30 and 100 micrograms/site, i.d.) was dose- and time-dependent in both groups of mice. At the lower doses of antibody, 10 and 30 micrograms/site, exudation was significantly less (30% and 40%, respectively) in W/Wv as compared to +/+ mice between 15 to 45 min. With 100 micrograms of antibody/site, significant differences between W/Wv and +/+ mice were noted only at 15 and 30 min. The deficit in permeability changes in W/Wv mice was reversed by local mast cell reconstitution. In +/+ mice, pyrilamine and methysergide pretreatment reduced vascular permeability to the same extent by 70, 60 and 35% when stimulated for 30 min with 10, 30 and 100 micrograms of antibody/site, respectively. An equivalent inhibition was observed with the 5-lipoxygenase inhibitor A-63162. None of the inhibitors decreased plasma permeation in W/Wv mice. These results indicate that the mast cell mediators histamine and serotonin regulate vascular permeability early during an immune complex-mediated inflammation. The data also suggest the involvement of leukotrienes and the importance of mast cells in their synthesis. The profile of inhibition in +/+ mice agrees well with the difference in exudation observed between normal and mast cell-deficient mice.
Asunto(s)
Reacción de Arthus/fisiopatología , Permeabilidad Capilar , Mastocitos/fisiología , Animales , Degranulación de la Célula , Leucotrienos/farmacología , RatonesRESUMEN
Current evidence suggests that intravascular coagulation (IC), an intermediary mechanism, is the most likely final common pathway by which intraosseous fat embolism causes nontraumatic osteonecrosis (ON). Stage 1A lesions (fatty osteocytic necrosis) appear to progress to classic Stage 1B lesions (ischemic degeneration of necrotic osteocytes and adipocytes) when the ischemic threshold is exceeded by absolute subchondral fat overload with insufficient local clearance of procoagulants, especially tissue thromboplastin. The result is vascular stasis, hypercoagulability, endothelial damage (by free fatty acids) and IC, especially if there is coexistent subchondral vasoconstriction and impaired secondary fibrinolysis. Osteonecrosis can be produced in animals by IC, which begins in the vulnerable subchondral microcirculation (Arthus phenomenon). Cartography (embolic scintimetry with superselective angiography) indicates early complete devascularization of the femoral head, suggesting progressive venous and retrograde arterial thrombosis. Increased plasma fibrinopeptide A and direct histologic evidence of intraosseous thromboses and peripheral hemorrhages further indicate that IC is the final pathway. Best evidence are 51 ON lesions complicating disseminated IC in eight children (Shwartzman phenomenon), with collateral histologic evidence of intraosseous thrombosis and ON.
Asunto(s)
Osteonecrosis/etiología , Trombosis/fisiopatología , Animales , Reacción de Arthus/fisiopatología , Presión Atmosférica , Coagulación Intravascular Diseminada/fisiopatología , Embolia Grasa/etiología , Embolia Grasa/fisiopatología , Endotoxinas/toxicidad , Hemorragia/fisiopatología , Humanos , Osteonecrosis/fisiopatología , Conejos , Factores de Riesgo , TortugasRESUMEN
A novel and potent antagonist of platelet-activating factor (PAF), Y-24180 (4-(2-chlorophenyl)-2-[2-(4-isobutylphenyl)ethyl]-6,9-dimethyl-6H- thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4] diazepine) was investigated for the effects on the skin reactions induced by chemical mediators and the Arthus reactions. In the rat dorsal skin, Y-24180 (0.1-10 mg/kg, p.o.) inhibited increase in vascular permeability by the intradermal PAF injection in a dose dependent manner and the inhibitory activity was 60 times more potent than that of WEB 2086. While even at doses as large as 10 mg/kg, p.o., it had no effect on vascular permeability in the rat skin induced by histamine, serotonin, bradykinin and leukotriene D4. On a reversed passive Arthus reaction in rat dorsal skin, Y-24180 (0.1-1 mg/kg, p.o.) markedly inhibited vascular permeability in a dose dependent manner and the inhibitory activity was 15 times more potent than that of WEB 2086. Y-24180 also inhibited the Arthus dermal reaction in rabbits (0.03-0.3 mg/kg, p.o.) and guinea pigs (0.1-1 mg/kg, p.o.). In addition, Y-24180 (0.1-10 mg/kg, p.o.) significantly reduced the exudate volume and the number of infiltrated inflammatory cells in the reversed passive Arthus pleural reaction in rats. Furthermore, in rat passive Arthus pancreatitis, Y-24180 (0.3-10 mg/kg, p.o.) significantly inhibited the dye extravasation from the pancreas. These results provide strong evidence that endogenous PAF plays an important role as a mediator in the type III allergic inflammation.
Asunto(s)
Reacción de Arthus/tratamiento farmacológico , Azepinas/farmacología , Permeabilidad Capilar/efectos de los fármacos , Factor de Activación Plaquetaria/fisiología , Piel/irrigación sanguínea , Triazoles/farmacología , Animales , Reacción de Arthus/complicaciones , Reacción de Arthus/fisiopatología , Modelos Animales de Enfermedad , Femenino , Cobayas , Masculino , Estructura Molecular , Ovalbúmina/inmunología , Pancreatitis/tratamiento farmacológico , Pancreatitis/etiología , Factor de Activación Plaquetaria/antagonistas & inhibidores , Conejos , Ratas , Ratas Endogámicas , Enfermedades de la Piel/inducido químicamente , Enfermedades de la Piel/etiologíaRESUMEN
Methionine-enkephalin (Met-Enk) and leucine-enkephalin (Leu-Enk) belong to family of opioid peptides. In vivo studies on immunomodulating activity of enkephalins performed in the rat revealed the following: (a) both neuropentapeptides showed a dual, dose-dependent effect, i.e., high doses suppressed while low doses potentiated immune responses; (b) Met-Enk is more potent immunomodulator than Leu-Enk; (c) high doses of Met-Enk suppressed immune inflammatory reactions, such as systemic anaphylactic shock, Arthus and delayed hypersensitivity skin reactions to protein antigen, allograft rejection, adjuvant arthritis, and experimental allergic encephalomyelitis. Met-Enk is more efficient when applied intracerebroventricularly. A preliminary clinical trial showed that intrathecally given Met-Enk exerted a beneficial effect on 13 patients with chronic severe progressive multiple sclerosis.